Stay updated on Belantamab vs Bortezomib in MM Clinical Trial
Sign up to get notified when there's something new on the Belantamab vs Bortezomib in MM Clinical Trial page.

Latest updates to the Belantamab vs Bortezomib in MM Clinical Trial page
- Check7 days agoChange DetectedDeleted the study disease name 'Multiple myeloma' and removed the 'MedlinePlus related topics' section, including the 'MedlinePlus Genetics' link. This reduces visibility of the principal condition and related resources.SummaryDifference0.1%

- Check14 days agoChange DetectedRevision: v3.4.2 has been added, and the previous notices about government funding lapse and the Revision: v3.4.1 have been removed.SummaryDifference0.2%

- Check21 days agoChange DetectedAdded a site-wide Notice about a lapse in government funding and that the NIH Clinical Center is open, with references to cc.nih.gov and opm.gov. Updated the platform revision from v3.4.0 to v3.4.1.SummaryDifference0.2%

- Check28 days agoChange DetectedThe updates are UI and metadata changes, such as showing a glossary, adding related topic tags (Multiple Myeloma, MedlinePlus Genetics), and revision metadata; no core study content, eligibility criteria, or results were altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check35 days agoChange DetectedRemoved the related topics: 'Multiple myeloma' and 'MedlinePlus Genetics'. These are metadata entries used for indexing and do not affect the study content.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4 on the page; no user-facing content or functional changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Belantamab vs Bortezomib in MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belantamab vs Bortezomib in MM Clinical Trial page.